A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - A preliminary report

We initially observed a phenomenon of reduced in vitro binding of exogenous cobalt [Co(II)] to the N-terminus of human serum albumin (HSA) in emergency chest pain patients with early onset unstable angina and myocardial infarction, We then developed a colorimetric assay to measure cobalt-HSA binding and record the results in absorbance units (ABSU), In a preliminary clinical study of 139 emergency patients with acute chest pain, 99 patients with evidence of myocardial Ischemia (Group I) had elevated assay levels (mean ABSU +/- SD; 0.519 +/- 0.086) compared to 40 patients (Group 2) with no evidence of ischemia (0.316 +/- 0.092) (p < 0.00001), In Group 1, 95 of 99 (96.0%) patients had levels higher than a decision threshold of 0.400 ABSU and in Group 2, 37 of 40 (92.5%) samples had higher cobalt binding capacity (ABSU <less than or equal to> 0.400). Further studies are warranted to determine if an assay measuring altered cobalt-HSA binding is a clinically useful diagnostic test to rule out myocardial ischemia, (C) 2000 Elsevier Science Inc.